Table 5.
Parameter | Value | Unit |
---|---|---|
Years to scale up MSAT | 1 | Years |
New coverage of MSAT | 90 | % |
Sensitivity HS RDT (clinical infections) | 99 | % |
Sensitivity HS RDT (asymptomatic, microscopically detectable) | 87 | % |
Sensitivity HS RDT (asymptomatic, microscopically undetectable) | 44 | % |
These parameters are from the “Interventions under trial: Focal MSAT (mobile)” tab in the modelling tool